The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
Open accessAbstract
BACKGROUND: In addition to nonmodifiable genetic risk factors, potentially modifiable factors such as hypertension, hyperlipidemia and environmental exposures have been identified as risk factors for Alzheimer disease. In this article, we provide physicians with practical guidance on risk assessment and primary prevention of Alzheimer disease based on recommendations from the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, held in March 2006. METHODS: We developed evidence-based guidelines using systematic literature searches, with specific criteria for study selection and quality assessment, and a clear and transparent decision-making process. We selected studies published from January 1996 to December 2005 that met the following criteria: dementia (all-cause, Alzheimer disease or vascular dementia) as the outcome; longitudinal cohort study; study population broadly reflective of Canadian demographics; and genetic risk factors and general risk factors (e.g., hypertension, education, occupation and chemical exposure) identified. We graded the strength of evidence using the criteria of the Canadian Task Force on Preventive Health Care. RESULTS: Of 3424 articles on potentially modifiable risk factors for dementia, 1719 met our inclusion criteria; 60 were deemed to be of good or fair quality. Of 1721 articles on genetic risk factors, 62 that met our inclusion criteria were deemed to be of good or fair quality. On the basis of evidence from these articles, we made recommendations for the risk assessment and primary prevention of Alzheimer disease. For the primary prevention of Alzheimer's disease, there is good evidence for controlling vascular risk factors, especially hypertension (grade A), and weak or insufficient evidence for manipulation of lifestyle factors and prescribing of medications (grade C). There is good evidence to avoid estrogens and high-dose (> 400 IU/d) of vitamin E for this purpose (grade E). Genetic counselling and testing may be offered to at-risk individuals with an apparent autosomal dominant inheritance (grade B). Screening for the apolipoprotein E genotype in asymptomatic individuals in the general population is not recommended (grade E). INTERPRETATION: Despite the personal and societal burden of dementia, our understanding of genetic predisposition to dementias and the contribution of other risk factors remains limited. More importantly, there are few data to explain the overall risks and benefits of prevention strategies or their impact of risk modification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Physical activity and risk of cognitive impairment and dementia in elderly persons
Laurin, D., Verreault, R., Lindsay, J., MacPherson, K., & Rockwood, K. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.498 · Cited by 1,561
Long-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
Willis, S. L., Tennstedt, S. L., Marsiske, M., Ball, K., Elias, J., Koepke, K. M., Morris, J. N., Rebok, G. W., Unverzagt, F. W., Stoddard, A. M., et al. (2006) · JAMA · doi:10.1001/jama.296.23.2805 · Cited by 1,496
Forette, F., Seux, M.-L., Staessen, J. A., Thijs, L., Birkenhäger, W. H., Babarskiene, M.-R., Babeanu, S., Bossini, A., Gil-Extremera, B., Girerd, X., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03086-4 · Cited by 1,441
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Kivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126
Wang, H.-X. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.12.1081 · Cited by 967
Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias
Plassman, B. L., Havlik, R. J., Steffens, D. C., Helms, M. J., Newman, T. N., Drosdick, D., Phillips, C., Gau, B. A., Welsh–Bohmer, K. A., Burke, J. R., et al. (2000) · Neurology · doi:10.1212/wnl.55.8.1158 · Cited by 896
Dietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895 · cited 1×
“fatty acids have been linked to an increased risk of dementia in epidemiologic studies.(40) A recent longitudinal study has also”
BackgroundInfluence of leisure activity on the incidence of Alzheimer's disease
Scarmeas, N., Levy, G., Tang, M.-X., Manly, J., & Stern, Y. (2001) · Neurology · doi:10.1212/wnl.57.12.2236 · Cited by 831
Dementia and Alzheimer Disease Incidence: A Prospective Cohort Study
Kukull, W. A., Higdon, R., Bowen, J. D., McCormick, W. C., Teri, L., Schellenberg, G. D., van Belle, G., Jolley, L., & Larson, E. B. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1737 · Cited by 806
Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302553 · Cited by 785
Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses
Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh-Sorensen, P., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.78 · Cited by 758
Podewils, L. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi092 · Cited by 675
Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease
Notkola, I.-L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 669
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
LeBlanc, E. S., Janowsky, J., Chan, B. K. S., & Nelson, H. D. (2001) · JAMA · doi:10.1001/jama.285.11.1489 · Cited by 659
Mediterranean Diet, Alzheimer Disease, and Vascular Mediation
Scarmeas, N., Stern, Y., Mayeux, R., & Luchsinger, J. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.noc60109 · Cited by 434
Dietary factors and Alzheimer's disease
Luchsinger, J. A., & Mayeux, R. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00878-6 · Cited by 433
Heart Protection Study Collaborative Group (2011) · The Lancet · doi:10.1016/s0140-6736(11)61125-2 · Cited by 373
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
ADAPT Research Group (2007) · Neurology · doi:10.1212/01.wnl.0000260269.93245.d2 · Cited by 354
Genest, J. J., Frohlich, J. J., Fodor, G. J., & McPherson, R. (2003) · PubMed · Cited by 342
Reduced incidence of AD with NSAID but not H2receptor antagonists: The Cache County Study
Zandi, P. P., Anthony, J. C., Hayden, K. M., Mehta, K., Mayer, L., & Breitner, J. C. S. (2002) · Neurology · doi:10.1212/wnl.59.6.880 · Cited by 316
Zandi, P. P. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.217 · Cited by 310
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant
Sherrington, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.985 · Cited by 309
Low Blood Pressure and Risk of Dementia in the Kungsholmen Project: A 6-Year Follow-up Study
Qiu, C., von Strauss, E., Fastbom, J., Winblad, B., & Fratiglioni, L. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.223 · Cited by 291
Shepherd, J., Blauw, G. J., & Murphy, M. B. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00040-0 · Cited by 273
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada
Tyas, S. L., Manfreda, J., Strain, L. A., & Montgomery, P. R. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.590 · Cited by 272
Results of a high-resolution genome screen of 437 Alzheimer's Disease families
Blacker, D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg007 · Cited by 262
Larner, A. J., & Doran, M. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0019-5 · Cited by 256
Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study
Li, G., Higdon, R., Kukull, W. A., Peskind, E., Van Valen Moore, K., Tsuang, D., van Belle, G., McCormick, W., Bowen, J. D., Teri, L., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142963.90204.58 · Cited by 246
Full genome screen for Alzheimer disease: Stage II analysis*
Myers, A., Wavrant De‐Vrieze, F., Holmans, P., Hamshere, M., Crook, R., Compton, D., Marshall, H., Meyer, D., Shears, S., Booth, J., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10183 · Cited by 207
Presenilin mutations in Alzheimer's disease
Cruts, M., & Van Broeckhoven, C. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:3<183::aid-humu1>3.0.co;2-j · Cited by 199
Identification of Novel Genes in Late-Onset Alzheimer's Disease
Pericak-Vance, M. A., Grubber, J., Bailey, L. R., Hedges, D., West, S., Santoro, L., Kemmerer, B., Hall, J. L., Saunders, A. M., Roses, A. D., et al. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00196-0 · Cited by 197
Severe Dementia: Prevalence and Clinical Features in a Biracial US Population
Schoenberg, B. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04210090004002 · Cited by 185
Almeida, O. P., Hulse, G. K., Lawrence, D., & Flicker, L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00016.x · Cited by 175
Vitamin C and Vitamin E for Alzheimer's Disease
Boothby, L. A., & Doering, P. L. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e495 · Cited by 174
Cupples, L. A., Farrer, L. A., De Sadovnick, A. S., Relkin, N., Whitehouse, P., & Green, R. C. (2004) · Genetics in Medicine · doi:10.1097/01.gim.0000132679.92238.58 · Cited by 166
Lee, J. H., Cheng, R., Schupf, N., Manly, J. J., Lantigua, R., Stern, Y., Rogaeva, E. A., Wakutani, Y., Farrer, L. A., George‐Hyslop, P. S., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.501 · Cited by 146
Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort.
Larrieu, S., Letenneur, L., Helmer, C., Dartigues, J. F., & Barberger‐Gateau, P. (2004) · PubMed · Cited by 136
Meta-Analysis of Nonsteroidal Antiinflammatory Drug Use and Risk of Dementia
de Craen, A. J. M., Gussekloo, P. J., Vrijsen, B., & Westendorp, R. G. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi029 · Cited by 124
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor‐Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Güallar, E. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.04.017 · Cited by 122
Feigin, V. L., Ratnasabapathy, Y., & Anderson, C. S. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.020 · Cited by 103
General risk factors for dementia: A systematic evidence review
Patterson, C., Feightner, J., Garcia, A. A., & MacKnight, C. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.07.001 · Cited by 98
Self-citationStatins for the prevention of Alzheimer's disease and dementia
Scott, H. D., & Laake, K. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160 · Cited by 92
the Heart Protection Study Collaborative Group (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00911-x · Cited by 89
Novel mutations and repeated findings of mutations in familial Alzheimer disease
Finckh, U., Kuschel, C., Anagnostouli, M. C., Patsouris, E., Pantes, G. V., Gatzonis, S. D., Kapaki, E. N., Davaki, P., Lamszus, K., Stavrou, D., et al. (2005) · Neurogenetics · doi:10.1007/s10048-005-0211-x · Cited by 87
Chertkow, H. M. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070795 · Cited by 86
Kim, K. R., Nam, S. Y., Song, Y. D., Lim, S. K., Lee, H. C., & Huh, K. B. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023319 · Cited by 84
Familial clustering and genetic risk for dementia in a genetically isolated Dutch population
Sleegers, K., Roks, G., Theuns, J., Aulchenko, Y. S., Rademakers, R., Cruts, M., van Gool, W. A., Broeckhoven, C. V., Heutink, P., Oostra, B. A., et al. (2004) · Brain · doi:10.1093/brain/awh179 · Cited by 70
Genetics and dementia: Risk factors, diagnosis, and management
Hsiung, G. R., & Sadovnick, A. D. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.07.010 · Cited by 52
Self-citationHormone Replacement Therapy and Cognition
LeBlanc, E. S., Chan, B. K. S., & Hd, N. (2002) · Cited by 51
Shumaker, S. A., Legault, C., Kuller, L. H., Rapp, S. R., Thal, L. J., Lane, D. S., Fillit, H. M., Stefanick, M. L., Hendrix, S. L., Lewis, C. E., et al. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000140470.91959.32 · Cited by 49
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-Analysis
LeBlanc, E. S., Janowsky, J. S., Chan, B. K. S., & Nelson, H. D. (2001) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200109000-00021 · Cited by 48
Results of a high-resolution genome screen of 437 Alzheimer's Disease families
Blacker, D. (2002) · Human Molecular Genetics · doi:10.1093/hmg/12.1.23 · Cited by 23
Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study
Etminan, M., & Fitzgerald, A. S. M. (2019) · Cited by 21
Statin therapy and risk of dementia in the elderly
Etminan, M., Fitzgerald, M., & Samii, A. (2005) · Neurology · doi:10.1212/wnl.64.7.1319 · Cited by 11
Cited by
ESPEN guidelines on nutrition in dementia
Volkert, D., Chourdakis, M., Faxen-Irving, G., Frühwald, T., Landi, F., Suominen, M. H., Vandewoude, M., Wirth, R., & Schneider, S. M. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.09.004 · Cited by 442
Diagnosis and treatment of dementia: 2. Diagnosis
Feldman, H. H., Jacova, C., Robillard, A., Garcia, A., Chow, T., Borrie, M., Schipper, H. M., Blair, M., Kertesz, A., & Chertkow, H. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.070798 · Cited by 354
Self-citationAlzheimer’s disease: analyzing the missing heritability
Ridge, P. G., Mukherjee, S., Crane, P. K., Kauwe, J. S. K., & Alzheimer’s Disease Genetics Consortium (2013) · PLoS ONE · doi:10.1371/journal.pone.0079771 · Cited by 328
van Oostveen, W. M., & de Lange, E. C. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042110 · Cited by 297
A Perspective on Multi-target Drugs for Alzheimer’s Disease
Benek, O., Korabecny, J., & Soukup, O. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.04.008 · Cited by 260
Metadata
- Authors
- Patterson, C., Feightner, J. W., Garcia, A., Hsiung, G.-Y. R., MacKnight, C., & Sadovnick, A. D.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2008-02-26
- Volume
- 178
- Issue
- 5
- Pages
- 548-556
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2158173241
- Cited by
- 268
- References
- 68
- FWCI
- 19.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.